High-Throughput and Site-Specific N-Glycosylation Analysis of Human Alpha-1-Acid Glycoprotein Offers a Great Potential for New Biomarker Discovery
Open Access
- 1 January 2021
- journal article
- research article
- Published by Elsevier BV in Molecular & Cellular Proteomics
- Vol. 20, 100044
- https://doi.org/10.1074/mcp.ra120.002433
Abstract
No abstract availableKeywords
Funding Information
- European Commission
This publication has 72 references indexed in Scilit:
- Serum Glycan Markers for Evaluation of Disease Activity and Prediction of Clinical Course in Patients with Ulcerative ColitisPLOS ONE, 2013
- Adipocytokine Orosomucoid Integrates Inflammatory and Metabolic Signals to Preserve Energy Homeostasis by Resolving Immoderate InflammationJournal of Biological Chemistry, 2010
- Hyperglycaemia in critical illness is a risk factor for later development of type II diabetes mellitusActa Diabetologica, 2009
- The heterogeneity of the glycosylation of alpha-1-acid glycoprotein between the sera and synovial fluid in rheumatoid arthritisBiomedical Chromatography, 2002
- Increased α3‐fucosylation of α1‐acid glycoprotein in patients with congenital disorder of glycosylation type IA (CDG‐Ia)FEBS Letters, 2001
- Alpha-1-acid glycoproteinBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 2000
- Microheterogeneity of the carbohydrate moiety of human alpha 1-acid glycoprotein in two benign liver diseases: Alcoholic cirrhosis and acute hepatitisClinica Chimica Acta; International Journal of Clinical Chemistry, 1989
- 400‐MHz 1H‐NMR spectroscopy of fucosylated tetrasialyl oligosaccharides isolated from normal and cirrhotic α1‐acid glycoproteinFEBS Letters, 1988
- Alterations in relative proportions of microheterogenous forms of human α1-acid glycoprotein in liver diseaseJournal of Hepatology, 1986
- Pharmacokinetics of Intravenously Administered 125I-Labelled Human α1-Acid GlycoproteinClinical Pharmacokinetics, 1986